Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 27, 2023
Nectin Therapeutics Ltd. (Nectin), a biotechnology firm dedicated to developing innovative targeted immunotherapies to overcome resistance to approved immune oncology treatments, has announced significant advancements in its Phase 1 clinical trial of...
read more
Monday, September 17, 2018
Nemaura Pharma has entered into a license agreement with a Global Pharma Company to develop 3 new Transdermal Patch products.
read more
Monday, February 25, 2019
Nemus Bioscience has signed an agreement with Pharmaceuticals International Inc. (Pii), a CDMO to develop a sterile eye drop dosage formulation of NB1111 for human dosing.
read more
Wednesday, August 22, 2018
Nemus Bioscience announced an agreement with AMRI for the development and manufacture of Nemus’ proprietary cannabinoid-based active pharmaceutical ingredients (API).
read more
NeoGenomics, a provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of Clarient, Inc. and its wholly-owned subsidiary Clarient Diagnostic Services, Inc. Clarient, a provider of comprehensive ...
read more
Tuesday, December 18, 2018
Hoffmann Neopac has earmarked two of its small-diameter Polyfoil tube solutions for production at its first U.S. manufacturing facility, which is scheduled to open in spring 2019.
read more
Monday, November 07, 2016
Neopharm Labs Inc. has announced its expansion into the United States with the strategic acquisition of Averica Discovery Services Inc. (Averica), a Contract Research Organization (CRO) based in the Greater Boston area with specialized expertise in ...
read more
Neovii and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon, in China and Japan.
read more
Neovii has signed a research and license agreement with Tel Aviv University to develop a novel COVID-19 vaccine.
read more
Friday, September 14, 2018
Nephron Pharmaceuticals is currently producing medications at its West Columbia, S.C. facility while monitoring the effects of Hurricane Florence.
read more
LSNE continues their expansion with the addition of increased cGMP storage capabilities at its 7 Commerce Drive facility located in Bedford, New Hampshire.
read more
Neuland Laboratories has brought online a fully operational dedicated Process Engineering Lab at its R&D Center.
read more
Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with further capacity expansions planned as client demand increases. The first of four planned modules is ...
read more
Monday, February 13, 2017
Neurocrine Biosciences and BIAL have entered into an exclusive licensing agreement for the development and commercialization of opicapone in North America. ONGENTYS® (opicapone) is a once-daily, peripherally-acting, highly-selective catechol-O-...
read more
Tuesday, January 14, 2020
Neurocrine Biosciences and Idorsia announced an amendment to the agreement granting Neurocrine Biosciences an option to license ACT-709478 for a rare pediatric epilepsy.
read more